financetom
Business
financetom
/
Business
/
Crescent Energy Swings to Q4 Loss, Revenue Rises; Quarterly Dividend Maintained
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Crescent Energy Swings to Q4 Loss, Revenue Rises; Quarterly Dividend Maintained
Feb 26, 2025 3:09 PM

05:41 PM EST, 02/26/2025 (MT Newswires) -- Crescent Energy ( CRGY ) reported a Q4 loss late Wednesday of $0.70 per diluted share, swinging from earnings of $0.61 a year earlier.

Analysts surveyed by FactSet expected EPS of $0.33.

Revenue for the quarter ended Dec. 31 was $875.3 million, up from $657.7 million a year earlier.

Analysts surveyed by FactSet expected $890.6 million.

The board maintained the quarterly dividend at $0.12 per share, payable on March 26 to shareholders of record on March 12.

Shares were down 1% in after-hours activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Shake Shack Q4 Earnings: Sales Soar 15%, Margins Expand And 85 New Locations On The Menu For 2025
Shake Shack Q4 Earnings: Sales Soar 15%, Margins Expand And 85 New Locations On The Menu For 2025
Feb 20, 2025
Shake Shack, Inc. ( SHAK ) shares are trading higher on Thursday. The company reported fourth-quarter adjusted earnings per share of 26 cents, beating the street view of 24 cents. Quarterly sales of $328.70 million (up 14.8% year over year), outpacing the analyst consensus estimate of $327.87 million. System-wide sales rose 13.3% to $500.7 million, while Same-Shack sales increased 4.3%. Shack...
Genmab Gets Japanese Regulatory Approval for Follicular Lymphoma Drug
Genmab Gets Japanese Regulatory Approval for Follicular Lymphoma Drug
Feb 20, 2025
09:55 AM EST, 02/20/2025 (MT Newswires) -- Genmab ( GMAB ) said Thursday that it has received Japanese regulatory approval for its Epkinly drug for the treatment of relapsed or refractory follicular lymphoma in patients who have received two or more prior lines of therapy. The approval from the Japan Ministry of Health, Labour and Welfare is based on results...
Cricket-Coca-Cola looks to bowl out Pepsi in Champions Trophy marketing contest
Cricket-Coca-Cola looks to bowl out Pepsi in Champions Trophy marketing contest
Feb 20, 2025
KARACHI (Reuters) - Coca-Cola is attempting to capitalise on Pakistan hosting its biggest cricket event in nearly 30 years, and steal the spotlight away from the host nation's official team sponsor Pepsi, by tapping into the country's love of 'tape-ball cricket'. International fixtures were halted in Pakistan after a 2009 attack on the Sri Lankan cricket team bus and only...
Amazon's MGM Studios gains creative control over 'James Bond' franchise
Amazon's MGM Studios gains creative control over 'James Bond' franchise
Feb 20, 2025
Feb 20 (Reuters) - Amazon MGM Studios will take creative control of the James Bond franchise under a new joint venture with longtime rights holders Michael Wilson and Barbara Broccoli, the tech giant said on Thursday. Amazon ( AMZN ) bought MGM Studios in 2022 as a part of its media push, which had granted the company distribution rights to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved